HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6
HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $9 to $6.
Last updated: 2026-11-19 03:50:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
LifeMD, Inc. (LFMD) operates in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE sector and is listed on NASDAQ. The stock is currently priced at $1.70, with a market capitalization of $89.42M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.60 to $5.38. This page covers its latest market performance, valuation, price trends and company information.
$89.42M | |
$1.75 | |
$1.94 | |
$1.67 | |
$1.80 | |
732.90K | |
900.04K | |
-- | |
$5.38 | |
$1.60 | |
3.57% | |
2026-09-30 |
LifeMD, Inc. (LFMD) last closed at $1.70 as of 2026-11-19 01:01:00, down 5.57% ($0.10) from the previous close of $1.80.
During the latest regular trading session, LFMD traded between $1.67 and $1.94, with a volume of 732.90K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, LifeMD, Inc. (LFMD) moved from $2.10 to $1.70, representing a decline of 19.09% ($0.40).
The stock traded between $1.60 and $2.34 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.35 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 2.5%
LFMD is currently trading at $1.70, placing it 2.5% of the way from its 52-week low of $1.60 to its 52-week high of $5.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Employees | 384 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to LifeMD, Inc. and LFMD stock.
HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $9 to $6.
LifeMD announced strategic shifts including direct pharmacy partnerships with Eli Lilly and Novo Nordisk for GLP-1 medications, a major enterprise collaboration with AT&T providing access to 100 million customers, and lower introductory pricing that increased multi-month subscriptions from 25% to 85%. The company expects flat overhead while patient volume grows, positioning it well in the virtual care and pharmacy market.
Lake Street analyst Ryan Meyers maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $5 to $3.
Gainers Cerenome (NASDAQ:CNSY) shares rose 39.5% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $5.8 million. As per the press release, Q3 earnings came out today. SBC
Mizuho analyst Steven Valiquette maintains LifeMD (NASDAQ:LFMD) with a Outperform and lowers the price target from $7 to $6.
Eligible investors can buy real shares of LifeMD, Inc. (LFMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to LFMD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between LFMD shares and USD.
LFMD Shares to USD
1.00 LFMD shares = 1.695 USD
Calculations are estimates based on the latest available price and are for reference only.